DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
To define the DNA methylation landscape of neuroblastoma and its clinicopathological impact. Microarray DNA methylation data were analyzed and associated with functional/regulatory genome annotation data, transcriptional profiles and clinicobiological parameters. DNA methylation changes in neuroblas...
Saved in:
Published in | Epigenomics Vol. 7; no. 7; pp. 1137 - 1153 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Future Medicine Ltd
01.10.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 1750-1911 1750-192X |
DOI | 10.2217/epi.15.49 |
Cover
Loading…
Abstract | To define the DNA methylation landscape of neuroblastoma and its clinicopathological impact.
Microarray DNA methylation data were analyzed and associated with functional/regulatory genome annotation data, transcriptional profiles and clinicobiological parameters.
DNA methylation changes in neuroblastoma affect not only promoters but also intragenic and intergenic regions at cytosine-phosphate-guanine (CpG) and non-CpG sites, and target functional chromatin domains of development and cancer-related genes such as
. Tumors with diverse clinical risk showed differences affecting CpG and, remarkably, non-CpG sites. Non-CpG methylation observed essentially in clinically favorable cases was associated with the differentiation status of neuroblastoma and expression of key genes such as
.
This epigenetic fingerprint of neuroblastoma provides new insights into the pathogenesis and clinical behavior of this pediatric tumor. |
---|---|
AbstractList | AIMTo define the DNA methylation landscape of neuroblastoma and its clinicopathological impact.MATERIALS & METHODSMicroarray DNA methylation data were analyzed and associated with functional/regulatory genome annotation data, transcriptional profiles and clinicobiological parameters.RESULTSDNA methylation changes in neuroblastoma affect not only promoters but also intragenic and intergenic regions at cytosine-phosphate-guanine (CpG) and non-CpG sites, and target functional chromatin domains of development and cancer-related genes such as CCND1. Tumors with diverse clinical risk showed differences affecting CpG and, remarkably, non-CpG sites. Non-CpG methylation observed essentially in clinically favorable cases was associated with the differentiation status of neuroblastoma and expression of key genes such as ALK.CONCLUSIONThis epigenetic fingerprint of neuroblastoma provides new insights into the pathogenesis and clinical behavior of this pediatric tumor. Aim: To define the DNA methylation landscape of neuroblastoma and its clinicopathological impact. Materials & methods: Microarray DNA methylation data were analyzed and associated with functional/regulatory genome annotation data, transcriptional profiles and clinicobiological parameters. Results: DNA methylation changes in neuroblastoma affect not only promoters but also intragenic and intergenic regions at cytosine-phosphate-guanine (CpG) and non-CpG sites, and target functional chromatin domains of development and cancer-related genes such as CCND1. Tumors with diverse clinical risk showed differences affecting CpG and, remarkably, non-CpG sites. Non-CpG methylation observed essentially in clinically favorable cases was associated with the differentiation status of neuroblastoma and expression of key genes such as ALK. Conclusion: This epigenetic fingerprint of neuroblastoma provides new insights into the pathogenesis and clinical behavior of this pediatric tumor. To define the DNA methylation landscape of neuroblastoma and its clinicopathological impact. Microarray DNA methylation data were analyzed and associated with functional/regulatory genome annotation data, transcriptional profiles and clinicobiological parameters. DNA methylation changes in neuroblastoma affect not only promoters but also intragenic and intergenic regions at cytosine-phosphate-guanine (CpG) and non-CpG sites, and target functional chromatin domains of development and cancer-related genes such as CCND1. Tumors with diverse clinical risk showed differences affecting CpG and, remarkably, non-CpG sites. Non-CpG methylation observed essentially in clinically favorable cases was associated with the differentiation status of neuroblastoma and expression of key genes such as ALK. This epigenetic fingerprint of neuroblastoma provides new insights into the pathogenesis and clinical behavior of this pediatric tumor. To define the DNA methylation landscape of neuroblastoma and its clinicopathological impact. Microarray DNA methylation data were analyzed and associated with functional/regulatory genome annotation data, transcriptional profiles and clinicobiological parameters. DNA methylation changes in neuroblastoma affect not only promoters but also intragenic and intergenic regions at cytosine-phosphate-guanine (CpG) and non-CpG sites, and target functional chromatin domains of development and cancer-related genes such as . Tumors with diverse clinical risk showed differences affecting CpG and, remarkably, non-CpG sites. Non-CpG methylation observed essentially in clinically favorable cases was associated with the differentiation status of neuroblastoma and expression of key genes such as . This epigenetic fingerprint of neuroblastoma provides new insights into the pathogenesis and clinical behavior of this pediatric tumor. |
Author | Loring, Jeanne F Lemos, Isadora Suñol, Mariona Nazor, Kristopher L Queiros, Ana Mora, Jaume de Torres, Carmen Mayol, Gemma Gómez, Soledad Rodríguez, Eva Bibikova, Marina Lavarino, Cinzia Castellano, Giancarlo Martín-Subero, José I |
AuthorAffiliation | 1Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Edificio Docente 4th floor, C/Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain 3Department of Pathology, Hospital Sant Joan de Déu, Barcelona, 08950, Spain 6Department of Anatomic Pathology, Pharmacology & Microbiology, University of Barcelona, Barcelona, 08036, Spain 2Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain 4Illumina, Inc., San Diego, CA 92122, USA 5Center for Regenerative Medicine, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA |
AuthorAffiliation_xml | – name: 1Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Edificio Docente 4th floor, C/Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain – name: 5Center for Regenerative Medicine, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA – name: 2Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain – name: 3Department of Pathology, Hospital Sant Joan de Déu, Barcelona, 08950, Spain – name: 6Department of Anatomic Pathology, Pharmacology & Microbiology, University of Barcelona, Barcelona, 08036, Spain – name: 4Illumina, Inc., San Diego, CA 92122, USA |
Author_xml | – sequence: 1 givenname: Soledad surname: Gómez fullname: Gómez, Soledad – sequence: 2 givenname: Giancarlo surname: Castellano fullname: Castellano, Giancarlo – sequence: 3 givenname: Gemma surname: Mayol fullname: Mayol, Gemma – sequence: 4 givenname: Mariona surname: Suñol fullname: Suñol, Mariona – sequence: 5 givenname: Ana surname: Queiros fullname: Queiros, Ana – sequence: 6 givenname: Marina surname: Bibikova fullname: Bibikova, Marina – sequence: 7 givenname: Kristopher L surname: Nazor fullname: Nazor, Kristopher L – sequence: 8 givenname: Jeanne F surname: Loring fullname: Loring, Jeanne F – sequence: 9 givenname: Isadora surname: Lemos fullname: Lemos, Isadora – sequence: 10 givenname: Eva surname: Rodríguez fullname: Rodríguez, Eva – sequence: 11 givenname: Carmen surname: de Torres fullname: de Torres, Carmen – sequence: 12 givenname: Jaume surname: Mora fullname: Mora, Jaume – sequence: 13 givenname: José I surname: Martín-Subero fullname: Martín-Subero, José I – sequence: 14 givenname: Cinzia surname: Lavarino fullname: Lavarino, Cinzia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26067621$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUFPHSEUhUljU6110T_QTNJNu3hPLjPAsDTWtiambmzSrgjD3HliGHgFpo3_XupTF0Y2cMh3bu499y3ZCzEgIe-BrhkDeYxbtwa-7tQrcgCS0xUo9mvv6Q2wT45yvqH1tKxXAt6QfSaokILBAfn95cdJM2O5vvWmuBiayYUNpm1yoTRxagIuKQ7e5BJn0yT8i8bn-vuvGVz0ceOs8Y0JY2O9C_fChew21yW_I6-nyuLRw31Ifn49uzr9vrq4_HZ-enKxsp2gZQX9QMdhkmBBtaPk0JtBWBT9aJhAxXvLx74fuJm61khmxha45S0bYWCKI2sPyadd3W2KfxbMRc8uW_TeBIxL1iC7OjRtBa3ox2foTVxSqN1pxhR0UnWyr9SHB2oZZhx1zWI26VY_hlaBzzvApphzwukJAar_70TXnWjgulOVPX7GWlfuky7JOP-ig-8c01KWhNk6DBb1TtV-nHUBX_DdAU2DoRQ |
CitedBy_id | crossref_primary_10_1038_s12276_018_0077_2 crossref_primary_10_1093_bioinformatics_btaa930 crossref_primary_10_1007_s10555_020_09946_y crossref_primary_10_1158_0008_5472_CAN_15_2507 crossref_primary_10_1186_s13148_017_0431_6 crossref_primary_10_1016_j_bbih_2022_100572 crossref_primary_10_1038_s43587_024_00649_5 crossref_primary_10_3390_jpm11050395 crossref_primary_10_1038_sdata_2016_4 crossref_primary_10_1042_BSR20200826 crossref_primary_10_1038_s41598_019_55382_6 crossref_primary_10_1186_s12864_022_09061_y crossref_primary_10_18632_oncotarget_25084 crossref_primary_10_17816_MAJ112498 crossref_primary_10_2217_pgs_2017_0017 crossref_primary_10_3390_cells9091920 crossref_primary_10_3390_cells13141209 crossref_primary_10_3390_epigenomes3020009 crossref_primary_10_1007_s10126_017_9756_6 crossref_primary_10_3390_cancers12092710 crossref_primary_10_1155_2021_1615201 crossref_primary_10_1155_2022_4995196 crossref_primary_10_1002_mc_22591 crossref_primary_10_18632_oncotarget_25111 crossref_primary_10_1038_s41388_023_02742_2 crossref_primary_10_1093_bib_bbac575 crossref_primary_10_1158_1078_0432_CCR_17_2243 crossref_primary_10_3389_fimmu_2020_01322 crossref_primary_10_1073_pnas_1700655114 crossref_primary_10_1080_15592294_2016_1226739 crossref_primary_10_3389_fnins_2018_00937 crossref_primary_10_18632_oncotarget_14208 crossref_primary_10_1186_s12929_017_0319_y crossref_primary_10_1016_j_canlet_2016_11_020 |
Cites_doi | 10.1200/JCO.2008.16.6785 10.1038/nature08514 10.2217/epi.12.67 10.1158/1078-0432.CCR-11-2483 10.1016/j.stem.2012.02.013 10.1371/journal.pone.0043137 10.1038/ng.2493 10.1038/nrg3354 10.1038/sj.onc.1210675 10.1038/ng.2529 10.1016/j.cell.2013.06.018 10.1042/BJ20081834 10.1038/onc.2010.21 10.1016/j.canlet.2011.11.013 10.1038/ng.2443 10.1038/nrc3130 10.1016/j.canlet.2006.05.001 10.1073/pnas.97.10.5237 10.1038/nbt.1533 10.4161/epi.5.7.12702 10.1038/labinvest.2011.169 10.1158/1078-0432.CCR-11-2644 10.1101/gr.229102 10.1038/nature14248 10.1016/j.canlet.2008.08.019 10.1038/ng.969 10.1038/ng.2746 10.1126/science.1237905 10.1001/jama.2012.228 10.1038/leu.2013.4 10.1038/nature07261 10.1038/nature09798 10.1038/nrclinonc.2012.72 10.1016/j.ygeno.2011.07.007 10.1038/nrg3230 10.1093/hmg/ddu406 10.1186/1755-8794-1-36 10.1186/1476-4598-9-277 10.1200/JCO.1993.11.8.1466 10.1056/NEJMra072067 10.1016/j.bbagrm.2013.08.001 10.1038/75007 10.1093/jjco/hyt058 10.1038/nn.3607 10.1186/s13148-015-0054-8 10.1158/0008-5472.CAN-08-4419 10.1016/j.ajhg.2013.01.002 10.1016/S0140-6736(07)60983-0 10.1038/nrc1014 10.1158/1078-0432.CCR-06-2846 10.1371/journal.pone.0048401 10.1093/bioinformatics/btg405 10.1038/nature07397 10.1038/nature10910 10.1093/nar/gkt838 10.1016/j.bbrc.2014.07.007 10.1371/journal.pmed.0050114 10.1016/j.canlet.2014.03.022 10.1371/journal.pgen.0030157 |
ContentType | Journal Article |
Copyright | Cinzia Lavarino 2015. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Cinzia Lavarino – notice: 2015. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | FUMOA AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8AO 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO EHMNL FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P5Z P62 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
DOI | 10.2217/epi.15.49 |
DatabaseName | Future Medicine (Open Access) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One Community College ProQuest Central Korea UK & Ireland Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest Medical Library UK & Ireland Database ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Central Student MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FUMOA name: Future Medicine (Open Access) url: https://www.futuremedicine.com/action/showPublications?pubType=journal sourceTypes: Publisher – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Languages & Literatures Zoology |
EISSN | 1750-192X |
EndPage | 1153 |
ExternalDocumentID | 26067621 10_2217_epi_15_49 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 0R 3V. 53G 70G 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ ABUWG ACGFS ACPRK ADBBV AENEX AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS ARAPS BBAFP BBNVY BENPR BGLVJ BHPHI BPHCQ BVXVI DU5 EBS EHMNL EJD F5P FUMOA FYUFA H13 HCIFZ HZ IAO IEA IHR LK8 M1P M7P MV1 NTCAX O9- P62 PQEST PQQKQ PRINS PROAC PSQYO RFM --- 0R~ 4.4 AAWFG AAYXX ABJNI ACWKX AFFYO ALIPV CCPQU CITATION HMCUK HZ~ ITC M4Z OVD PHGZM PHGZT RPM TDBHL TEORI TFL TFMDE TMEDX UKHRP ABNDM CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQUKI 7X8 |
ID | FETCH-LOGICAL-c460t-18b0dbf71c193d7518ab6ce68da26e958c5d88b5af43a72ad315c532d1b295e23 |
IEDL.DBID | 7X7 |
ISSN | 1750-1911 |
IngestDate | Fri Jul 11 12:08:52 EDT 2025 Fri Jul 25 12:25:50 EDT 2025 Mon Jul 21 05:59:31 EDT 2025 Tue Jul 01 03:49:09 EDT 2025 Thu Apr 24 23:08:04 EDT 2025 Tue Jan 05 21:39:17 EST 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | ALK DNA methylome development CCND1 nonpromoter methylation neuroblastoma non-CpG sites |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c460t-18b0dbf71c193d7518ab6ce68da26e958c5d88b5af43a72ad315c532d1b295e23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.2217/epi.15.49 |
PMID | 26067621 |
PQID | 2291479478 |
PQPubID | 135346 |
PageCount | 17 |
ParticipantIDs | proquest_miscellaneous_1749610360 proquest_journals_2291479478 pubmed_primary_26067621 crossref_primary_10_2217_epi_15_49 crossref_citationtrail_10_2217_epi_15_49 futurescience_futuremedicine_10_2217_epi_15_49 |
ProviderPackageCode | RFM FUMOA NTCAX 70G CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-10-01 |
PublicationDateYYYYMMDD | 2015-10-01 |
PublicationDate_xml | – month: 10 year: 2015 text: 2015-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Epigenomics |
PublicationTitleAlternate | Epigenomics |
PublicationYear | 2015 |
Publisher | Future Medicine Ltd |
Publisher_xml | – name: Future Medicine Ltd |
References | e_1_3_6_30_1 e_1_3_6_53_1 e_1_3_6_32_1 e_1_3_6_55_1 e_1_3_6_11_1 e_1_3_6_51_1 e_1_3_6_15_1 e_1_3_6_38_1 e_1_3_6_13_1 e_1_3_6_19_1 e_1_3_6_34_1 e_1_3_6_57_1 e_1_3_6_17_1 e_1_3_6_36_1 e_1_3_6_59_1 e_1_3_6_42_1 e_1_3_6_65_1 e_1_3_6_21_1 e_1_3_6_44_1 e_1_3_6_63_1 e_1_3_6_61_1 e_1_3_6_40_1 e_1_3_6_6_1 e_1_3_6_4_1 e_1_3_6_8_1 e_1_3_6_27_1 e_1_3_6_29_1 e_1_3_6_23_1 e_1_3_6_46_1 e_1_3_6_25_1 e_1_3_6_48_1 e_1_3_6_31_1 e_1_3_6_52_1 e_1_3_6_33_1 e_1_3_6_54_1 e_1_3_6_10_1 e_1_3_6_50_1 e_1_3_6_14_1 e_1_3_6_39_1 e_1_3_6_12_1 e_1_3_6_18_1 e_1_3_6_35_1 e_1_3_6_56_1 e_1_3_6_16_1 e_1_3_6_37_1 e_1_3_6_58_1 e_1_3_6_20_1 e_1_3_6_41_1 e_1_3_6_22_1 e_1_3_6_43_1 e_1_3_6_64_1 e_1_3_6_62_1 e_1_3_6_60_1 e_1_3_6_5_1 e_1_3_6_3_1 e_1_3_6_9_1 e_1_3_6_7_1 e_1_3_6_28_1 e_1_3_6_49_1 e_1_3_6_24_1 e_1_3_6_45_1 e_1_3_6_26_1 e_1_3_6_47_1 |
References_xml | – ident: e_1_3_6_5_1 doi: 10.1200/JCO.2008.16.6785 – ident: e_1_3_6_14_1 doi: 10.1038/nature08514 – ident: e_1_3_6_21_1 doi: 10.2217/epi.12.67 – ident: e_1_3_6_35_1 doi: 10.1158/1078-0432.CCR-11-2483 – ident: e_1_3_6_37_1 doi: 10.1016/j.stem.2012.02.013 – ident: e_1_3_6_59_1 doi: 10.1371/journal.pone.0043137 – ident: e_1_3_6_9_1 doi: 10.1038/ng.2493 – ident: e_1_3_6_10_1 doi: 10.1038/nrg3354 – ident: e_1_3_6_45_1 doi: 10.1038/sj.onc.1210675 – ident: e_1_3_6_8_1 doi: 10.1038/ng.2529 – ident: e_1_3_6_46_1 doi: 10.1016/j.cell.2013.06.018 – ident: e_1_3_6_53_1 doi: 10.1042/BJ20081834 – ident: e_1_3_6_58_1 doi: 10.1038/onc.2010.21 – ident: e_1_3_6_34_1 doi: 10.1016/j.canlet.2011.11.013 – ident: e_1_3_6_43_1 doi: 10.1038/ng.2443 – ident: e_1_3_6_11_1 doi: 10.1038/nrc3130 – ident: e_1_3_6_23_1 doi: 10.1016/j.canlet.2006.05.001 – ident: e_1_3_6_65_1 – ident: e_1_3_6_16_1 doi: 10.1073/pnas.97.10.5237 – ident: e_1_3_6_49_1 doi: 10.1038/nbt.1533 – ident: e_1_3_6_12_1 doi: 10.4161/epi.5.7.12702 – ident: e_1_3_6_24_1 doi: 10.1038/labinvest.2011.169 – ident: e_1_3_6_26_1 doi: 10.1158/1078-0432.CCR-11-2644 – ident: e_1_3_6_62_1 – ident: e_1_3_6_38_1 doi: 10.1101/gr.229102 – ident: e_1_3_6_39_1 doi: 10.1038/nature14248 – ident: e_1_3_6_27_1 doi: 10.1016/j.canlet.2008.08.019 – ident: e_1_3_6_19_1 doi: 10.1038/ng.969 – ident: e_1_3_6_17_1 doi: 10.1038/ng.2746 – ident: e_1_3_6_13_1 doi: 10.1126/science.1237905 – ident: e_1_3_6_6_1 doi: 10.1001/jama.2012.228 – ident: e_1_3_6_18_1 doi: 10.1038/leu.2013.4 – ident: e_1_3_6_52_1 doi: 10.1038/nature07261 – ident: e_1_3_6_15_1 doi: 10.1038/nature09798 – ident: e_1_3_6_55_1 doi: 10.1038/nrclinonc.2012.72 – ident: e_1_3_6_36_1 doi: 10.1016/j.ygeno.2011.07.007 – ident: e_1_3_6_50_1 doi: 10.1038/nrg3230 – ident: e_1_3_6_31_1 doi: 10.1093/hmg/ddu406 – ident: e_1_3_6_33_1 doi: 10.1186/1755-8794-1-36 – ident: e_1_3_6_42_1 doi: 10.1186/1476-4598-9-277 – ident: e_1_3_6_32_1 doi: 10.1200/JCO.1993.11.8.1466 – ident: e_1_3_6_48_1 doi: 10.1056/NEJMra072067 – ident: e_1_3_6_20_1 doi: 10.1016/j.bbagrm.2013.08.001 – ident: e_1_3_6_29_1 doi: 10.1038/75007 – ident: e_1_3_6_64_1 – ident: e_1_3_6_25_1 doi: 10.1093/jjco/hyt058 – ident: e_1_3_6_47_1 doi: 10.1038/nn.3607 – ident: e_1_3_6_30_1 doi: 10.1186/s13148-015-0054-8 – ident: e_1_3_6_56_1 doi: 10.1158/0008-5472.CAN-08-4419 – ident: e_1_3_6_60_1 doi: 10.1016/j.ajhg.2013.01.002 – ident: e_1_3_6_3_1 doi: 10.1016/S0140-6736(07)60983-0 – ident: e_1_3_6_4_1 doi: 10.1038/nrc1014 – ident: e_1_3_6_22_1 doi: 10.1158/1078-0432.CCR-06-2846 – ident: e_1_3_6_40_1 doi: 10.1371/journal.pone.0048401 – ident: e_1_3_6_41_1 doi: 10.1093/bioinformatics/btg405 – ident: e_1_3_6_54_1 doi: 10.1038/nature07397 – ident: e_1_3_6_7_1 doi: 10.1038/nature10910 – ident: e_1_3_6_51_1 doi: 10.1093/nar/gkt838 – ident: e_1_3_6_61_1 doi: 10.1016/j.bbrc.2014.07.007 – ident: e_1_3_6_44_1 doi: 10.1371/journal.pmed.0050114 – ident: e_1_3_6_28_1 doi: 10.1016/j.canlet.2014.03.022 – ident: e_1_3_6_63_1 – ident: e_1_3_6_57_1 doi: 10.1371/journal.pgen.0030157 |
SSID | ssj0000328961 |
Score | 2.235444 |
Snippet | To define the DNA methylation landscape of neuroblastoma and its clinicopathological impact.
Microarray DNA methylation data were analyzed and associated with... Aim: To define the DNA methylation landscape of neuroblastoma and its clinicopathological impact. Materials & methods: Microarray DNA methylation data were... AIMTo define the DNA methylation landscape of neuroblastoma and its clinicopathological impact.MATERIALS & METHODSMicroarray DNA methylation data were analyzed... |
SourceID | proquest pubmed crossref futurescience |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1137 |
SubjectTerms | Adrenal glands Annotations Brain Neoplasms - diagnosis Brain Neoplasms - genetics Brain Neoplasms - metabolism Brain Neoplasms - mortality Cell Line, Tumor Child Child, Preschool Chromatin Chromatin - chemistry Chromatin - metabolism Cluster analysis CpG Islands Cyclin D1 - genetics Cyclin D1 - metabolism Cytosine Deoxyribonucleic acid development DNA DNA Fingerprinting DNA Methylation DNA methylome DNA microarrays DNA, Intergenic Domains Epigenesis, Genetic Female Fingerprints Gene expression Gene Expression Profiling Gene Expression Regulation, Neoplastic Genes Genome, Human Genomes Guanine Humans Infant Kinases Male Mutation Neuroblastoma Neuroblastoma - diagnosis Neuroblastoma - genetics Neuroblastoma - metabolism Neuroblastoma - mortality non-CpG sites nonpromoter methylation Oligonucleotide Array Sequence Analysis Pathogenesis Prognosis Promoter Regions, Genetic Receptor Protein-Tyrosine Kinases - genetics Receptor Protein-Tyrosine Kinases - metabolism Stem cells Survival Analysis Transcription Tumors |
SummonAdditionalLinks | – databaseName: Future Medicine (Open Access) dbid: FUMOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fS8MwED7mhiCI6NQ5nRJ_IL50Lm3Tpo9DHUPmnhxMX0rSpjDQdtgO8b_30nSDwXzwsW0CIZfLfd_l-gXgxpdeJIXjWzHTotoyCCwR9NCvbCYdETkYxMsq37E3nLjPUzatwfXGE3wb8fK9ms-6lHXdYAsatu9r72sMJi8Vcyo3XAdZg1FGxfhnIQOhRkNovf9a5Nk1kh1VmPkbXpZhZrAPexU-JH1j0AOoqbQJrVGVVczJLRmthJDzJmy_Z2Ve_BDeHsd9ou-D_jHVbSQpE3Y6b1eQLCGlcKVErFxkn4Jo4SZcePj2mxgdJm0sItKYLP-VJLM018w9P4LJ4On1YWhV9yZYkev1Coty2Ytl4tMI0Vmsz1UEWkR5PBa2pwLGIxZzLplIXEf4togdyiLm2DGVdsCU7RxDPc1SdQJEn9tJjiRLINTguLv5ScK1SJ-UCY1U0oa75ZyGUSUqru-2-AiRXOjpD3H6Q8pCN2jD1arp3ChpbGrUXTNMaJ6WdQabOnSWlgsr78uxSUC1cr7P23C5-ox-ow9DRKqyRR4iE8M1g_G714aWsfhqWMjxPAwS9PS_ozmDHQRUzBT7daBefC3UOYKWQl5Ui_YXGu_rBQ priority: 102 providerName: Future Medicine |
Title | DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights |
URI | http://dx.doi.org/10.2217/epi.15.49 https://www.ncbi.nlm.nih.gov/pubmed/26067621 https://www.proquest.com/docview/2291479478 https://www.proquest.com/docview/1749610360 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0RRBEtGp7tR6riPiS6-3mNtk8yVV7FqmniAenL8t-BQo2uTYpxf_emewmKlRfEvJJmNnd-c1HfkPIy9xk1ug0T5xAUm1TFIkupjCvuDCptikY8a7Kd5mdrGYf1mIdA25NLKvs18RuoXa1xRj5IecFQzb0XL7ZXCTYNQqzq7GFxm2yjdRlWNKVr_MhxoJccUWgTAXDmIBrwgK5EAcgfug3ZxMmJsii-YdJuhe4PKL9-Tfu7OzP4gG5H4EjnQdNPyS3fLVDdk9juLGhr-jpwJDc7JA73-suYP6IfHu3nFNsFP0zlL3RsovkYUCvpXVJO0ZLAyC6rc81RUYnGJFw9poGgibUItWVo_1PlPSsatClbx6T1eL469uTJDZUSOwsm7YJk2bqTJkzC7DNYcJFg6p8Jp3mmQf5WeGkNEKXs1TnXLuUCStS7pjhhfA8fUK2qrrye4RiQs9I8L40YBAJy15elhLZ-4wpmfXliLzuZapsZBvHphc_FHgdKH4F4ldMqFkxIi-GWzeBYuOmmyZ_KUaFo74A4aYHDnrNqTgtG_V7EI3I8-EyTCjMkujK11eNAhcNxgwY9umI7AaND58Fzl8G1oPt___lT8ldwFUi1PwdkK328so_A-zSmnE3QGErF-_HZPvoePn5C-wXq4-f5uMu1PQLt4Tz3A |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB1VRQikCkGBdmkBgwBxyXbtxIlzQKiiLFu67KmVChdjJ45UqU2WJlXVP8VvZCZOAkiFW49JnCiy5-PNePwG4FVi48yaMAlySaTaNk0Dk05Qr4S0oclCdOJtle8inh1Fn4_l8Qr87M_CUFllbxNbQ51XGeXId4RIObGhJ-r98kdAXaNod7VvoeHF4sBdXWLIVr_b38P1fS3E9OPhh1nQdRUIsiieNAFXdpLbIuEZYpecdh0M_q-LVW5E7FKpMpkrZaUpotAkwuQhl5kMRc6tSKUjogM0-beiMExJo9T005DTIW661FO0oiMOMBTinsxIIPDfccuTMZdjYu38wwWuee6Qzt_9G-e2_m56H-51QJXtesl6ACuuXIeNeZferNkbNh8Ymet1uP2tahP0D-Hr3mKXUWPqK19mx4o2c0gJxIZVBWsZNC2C9qY6M4wYpFAD8O4l84RQJDXMlDnrD22yk7KmFEL9CI5uZKofw2pZlW4TGG0gWoXRnkHMo9DMJkWhiC3Q2oJnrhjB235Oddaxm1OTjVONUQ5Nv8bp11zqKB3By2Ho0lN6XDdo_NfCaH_VFzxc98J2v3K6MwO1_i20I3gxPEYFpl0ZU7rqotYYEqLMIJCYjGDDr_jwWxhsxuit-JP_f_w53Jkdfpnr-f7iYAvuIqaTvt5wG1ab8wv3FHFTY5-1wsrg-01rxy8GZSvA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fa9RAEB9KRRFEtGo9rbqKii-5u93cZpMHkeJ5tPY4fLBw-rLuJrtQ0OQ0KaVfzU_nTDaJCtW3PibZhDA7_2f2NwDPlU1ya2IVFZJAtW2WRSabolwJaWOTx2jE2y7fVXJwPHu_lust-NmfhaG2yl4ntoq6qHLKkU-EyDihoat04ru2iA_zxZvN94gmSFGltR-nEVjkyJ2fYfhWvz6c416_EGLx7uPbg6ibMBDls2TaRDy108J6xXP0YwqqQBj8d5ekhRGJy2SayyJNrTR-FhslTBFzmctYFNyKTDoCPUD1f0XFkpOMqbUa8juEU5cFuFY0yhGGRTwAGwkMAiZuczLmckwInn-YwxsBR6Szff_2eVvbt7gFNzunle0HLrsNW67cgd1ll-qs2Uu2HNCZ6x24-rlqk_V34NN8tc9oSPV5aLljvs0iUjKxYZVnLZqmRQe-qb4ZRmhSKA1494wFcCjiIGbKgvUHONlJWVM6ob4Lx5dC6nuwXValuw-Miok2xcjPoP-TospV3qeEHGit57nzI3jV01TnHdI5Ddz4qjHiIfJrJL_mUs-yETwblm4CvMdFi8Z_bYwOV33zw0Uv7PU7pzuVUOvfDDyCp8NjFGaq0JjSVae1xvAQeQadiukIdsOOD7-FgWeClos_-P_Hn8A1lAu9PFwdPYTr6N7J0Hq4B9vNj1P3CF2oxj5ueZXBl8sWjl-m9y_t |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DNA+methylation+fingerprint+of+neuroblastoma+reveals+new+biological+and+clinical+insights&rft.jtitle=Epigenomics&rft.au=G%C3%B3mez%2C+Soledad&rft.au=Castellano%2C+Giancarlo&rft.au=Mayol%2C+Gemma&rft.au=Su%C3%B1ol%2C+Mariona&rft.date=2015-10-01&rft.eissn=1750-192X&rft.volume=7&rft.issue=7&rft.spage=1137&rft.epage=1153&rft_id=info:doi/10.2217%2Fepi.15.49&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-1911&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-1911&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-1911&client=summon |